A new model to predict the risk of major gastrointestinal bleeding in patients on direct oral anticoagulants (dabigatran and rivaroxaban).

Meina LvShaojun JiangTingting WuNianxu HuangXia ChenChunmei ChenJin-Hua Zhang

Published in: British journal of clinical pharmacology (2022)

Based on 12 factors, we developed a gastrointestinal bleeding risk score. The newly developed Alfalfa-DOAC-GIB score has better predictive value than the HAS-BLED score and the New score, and might be an effective tool to help reduce the occurrence of GIB in patients using DOACs.

Keyphrases

direct oral anticoagulants
end stage renal disease
atrial fibrillation
venous thromboembolism
ejection fraction
chronic kidney disease
newly diagnosed
prognostic factors
risk assessment